Ovarian Tissue Cryopreservation

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 30, 2020

Primary Completion Date

July 31, 2030

Study Completion Date

July 31, 2031

Conditions
Infertility, Female
Interventions
PROCEDURE

Ovarian tissue removal will be performed laparoscopically

under general anesthesia concomitantly with another scheduled procedure if possible. Following removal, ovarian tissue will be shipped to University of Pittsburg Medical Center, Magee-Womens Research Institute for processing. Freezing and storing techniques will be in accordance with FDA regulations for reproductive tissues, guidelines of the American Association of Tissues Banks and any other applicable federal, state and local regulations. The tissue will be carefully separated dividing the cortex from the medulla. The cortex will then be cryopreserved for long term storage. The medulla will be shipped overnight back to the PCH Department of Pathology for histological evaluation. If pathology finds evidence of cancer in the ovarian tissue provided, they may request that all of the patient's tissue be returned to pathology for a more detailed examination, which may eliminate the tissue available for the patient's future use.

Trial Locations (1)

85016

RECRUITING

Phoenix Childrens, Phoenix

All Listed Sponsors
lead

Phoenix Children's Hospital

OTHER